Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Chris Henshall"'
Autor:
Nicholas. R Latimer, Daniel Pollard, Adrian Towse, Chris Henshall, Lloyd Sansom, Robyn L Ward, Andrew Bruce, Carla Deakin
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possibl
Externí odkaz:
https://doaj.org/article/b1b72ee499994c958b5fe3a3fbbaff26
Autor:
Katharina Kieslich, Jeonghoon Ahn, Gabriele Badano, Kalipso Chalkidou, Leonardo Cubillos, Renata Curi Hauegen, Chris Henshall, Carleigh B Krubiner, Peter Littlejohns, Lanting Lu, Steven D Pearson, Annette Rid, Jennifer A Whitty, James Wilson
Publikováno v:
Journal of Health Organization and Management, 2016, Vol. 30, Issue 5, pp. 769-785.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JHOM-03-2016-0035
Publikováno v:
Journal of Comparative Effectiveness Research. 10:537-547
At the heart of all health insurance programs lies ethical tension between maximizing the freedom of patients and clinicians to tailor care for the individual and the need to make healthcare affordable. Nowhere is this tension more fiercely debated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1770c16e47d063d49de0192a9c30121
https://doi.org/10.2217/cer-2021-0027
https://doi.org/10.2217/cer-2021-0027
Publikováno v:
Journal of Comparative Effectiveness Research. 8:1045-1054
Alternative approaches to the current rebate system are being considered by policymakers and stakeholders in the private insurance market. This paper presents an analysis of three alternative options to the current rebate model: retaining retroactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0393092bcab1fc522455905b8730b5e2
https://doi.org/10.2217/cer-2019-0094
https://doi.org/10.2217/cer-2019-0094
Publikováno v:
Journal of Comparative Effectiveness Research. 7:1145-1152
Aim: To provide a framework for optimizing the development and use of real-world evidence (RWE) in drug coverage decisions. Materials & methods: The Institute for Clinical and Economic Review convened a Policy Summit with representatives from 23 paye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ddfa3b035aaf4a717feb87b5a135250
https://doi.org/10.2217/cer-2018-0059
https://doi.org/10.2217/cer-2018-0059
Autor:
Andrew Bruce, Carla Deakin, Nicholas Latimer, Lloyd Sansom, Chris Henshall, Daniel Pollard, Robyn L. Ward, Adrian Towse
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Background It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possible solutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87fd8f0cb4e991b4d7922ca8af024f40
https://eprints.whiterose.ac.uk/173534/8/s12913-021-06425-0.pdf
https://eprints.whiterose.ac.uk/173534/8/s12913-021-06425-0.pdf
Combination therapies are used to treat many cancers. Recently it has become common for newly developed add-on treatments to be combined with existing treatments that are relatively new and on-pate...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc1ba526791cefac278263706b55bde
Publikováno v:
Journal of Comparative Effectiveness Research. 7:15-28
Aims: To explore the challenges presented by gene therapies, discuss potential solutions, and present policy recommendations. Methods: A review of the literature and series of expert interviews were conducted and discussed at a Policy Forum convened
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd722701bded187185ce7bf613e696c4
https://doi.org/10.2217/cer-2017-0068
https://doi.org/10.2217/cer-2017-0068
Publikováno v:
Journal of Comparative Effectiveness Research. 6:397-404
Aim: To explore the potential of indication-specific pricing (ISP) of pharmaceuticals and to discuss prospects for implementation in the US healthcare system. Materials & methods: The Institute for Clinical and Economic Review convened a policy forum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baee90056c55f67a0568256f50a4b5df
https://doi.org/10.2217/cer-2017-0018
https://doi.org/10.2217/cer-2017-0018
Autor:
Rebecca Yu, Chris Henshall, Adrian D Griffin, Louis P. Garrison, Melissa Thompson, Stephen Long, Doug Coyle, Zayna A Khayat, Dana L Anger
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Melissa Thompson,1 Chris Henshall,2 Louis P Garrison,3 Adrian D Griffin,4 Doug Coyle,2,5 Stephen Long,6 Zayna A Khayat,7 Dana L Anger,1 Rebecca Yu8 1Cornerstone Research Group Inc., Burlington, ON, Canada; 2Health Economics Research Group, Brunel Uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb81a70fb273d5aff389ca50b1a4015
https://doi.org/10.2147/ceor.s96616
https://doi.org/10.2147/ceor.s96616